GLP-1 drugs, such as Ozempic and Wegovy, have revolutionized diabetes treatment but now hold promise for multiple other conditions. With millions already taking these medications, researchers are uncovering new uses for the treatments. Recent studies suggest GLP-1s may combat dementia, kidney and liver problems, alcohol dependence, and compulsive behaviors like addiction and shopping.
As more studies validate their potential, it’s reasonable to wonder if everyone should be taking Ozempic. However, current versions of these drugs require regular injections and are expensive. But with cheaper alternatives on the horizon, these medications may become a staple in healthcare soon. Eli Lilly is set to launch a pill version, making them more accessible to a wider audience.
The benefits of GLP-1s go beyond weight loss, offering hope for tackling America’s leading killer, cardiovascular disease. With continued research and development, it’s likely that Ozempic and other GLP-1 drugs will become a cornerstone of treatment for various conditions, transforming the way we approach healthcare.
Source: https://www.vox.com/the-highlight/420418/ozempic-glp-1-drugs-pill-forms-science